Allurion Technologies

In 2021, provide to your patients a 360° medical weight loss solution that helps patients reach a healthier weight and lifestyle, for good.​

Learn more at ​https://allurion.com/en/for-healthcare-professionals

​

This content describes our product, which has not been approved or cleared for marketing by the U.S. Food and Drug Administration. Our product is not available for sale in the United States.​

We love to hear how Allurion’s revolutionary Elipse Weight Loss Program impacts patients’ lives. We are thrilled to help people across the world reach their greatest potential. Thank you for trusting us!

If you wish to be part of world’s largest weight loss revolution, contact us today at https://allurion.com/en/for-healthcare-professionals



This content describes our product, which has not been approved or cleared for marketing by the U.S. Food and Drug Administration. Our product is not available for sale in the United States.

Celebrating new year with Elipse patients’ stories

Health is a precious gift! Allurion is committed to our mission to help people realize their full potential with innovative, personalized, & trusted experiences for weight-loss. Welcome 2021!

Learn more about our revolutionary weight-loss solution. Contact us today at https://allurion.com/en/for-healthcare-professionals



This content describes our product, which has not been approved or cleared for marketing by the U.S. Food and Drug Administration. Our product is not available for sale in the United States.

The new Allurion mobile app is out! It includes refreshed and modern branding and user experience, integrated technical support for users and new graphs of all historical scale data and trends.
Patients can also continue to send their health care team a file of all their body composition data and trends via email from the Allurion mobile app.



This content describes our product, which has not been approved or cleared for marketing by the U.S. Food and Drug Administration. Our product is not available for sale in the United States.

The New Allurion Smartphone App For Weight Loss Support Read more about Allurion's Elipse Weight Loss Program on: https://allurion.com/ We are proud to unveil our new smartphone app, that pairs with the Allurion i...

See you today! New Allurion Master Class to learn how to:
- improve your clinic's Elipse patient satisfaction
- recognize more complicated patient profiles and approach
- implement multidisciplinary strategies to maintain high patient satisfaction and reduce negative situations

Register now for this Master Class:
- 7am EDT / 1pm CET: http://bit.ly/AllurionMasterclass_PatientManagement
- 12pm EDT / 6pm CET: http://bit.ly/AllurionMasterclass_PatientManagement2



Not for US physicians - investigational use only in the US .
This content describes our product, which has not been approved or cleared for marketing by the U.S. Food and Drug Administration. Our product is not available for sale in the United States.

We are proud to share the latest clinical results from two studies: 95% of total body weight loss achieved during Elipse™ Balloon treatment is maintained at 1-year follow-up, and sequential balloon treatment achieves weight loss at 1-year that approximates bariatric surgery.

“Both of these studies demonstrate the potential that the Allurion Program has in providing consumers with long-term and sustainable results,” said Dr. Shantanu Gaur, co-founder and CEO of Allurion Technologies. “Additionally, this data indicates that consumers can achieve life-changing results without needing to undergo surgery, endoscopy or anaesthesia”.

Read the full press release here: https://www.businesswire.com/news/home/20201110005027/en/Allurion-Technologies-Announces-New-Clinical-Data-on-the-Elipse%C2%AE-Balloon-at-ObesityWeek%C2%AE-2020


This content describes our product, which has not been approved or cleared for marketing by the U.S. Food and Drug Administration. Our product is not available for sale in the United States.

See you today! The links between obesity and COVID-19 are undeniable and tackling this issue is critical. Join Allurion to understand the latest data-driven global insights and how the Allurion program is expanding globally during COVID.
Register now for this Master Class:
- 7am EDT / 1pm CET: http://bit.ly/AllurionMasterclass_CovidObesity
- 12pm EDT / 6pm CET: http://bit.ly/AllurionMasterclass_CovidObesity2



Not for US physicians - investigational use only in the US .
This content describes our product, which has not been approved or cleared for marketing by the U.S. Food and Drug Administration. Our product is not available for sale in the United States.

New Allurion Master Class to learn how to:
- improve your clinic's Elipse patient satisfaction
- recognize more complicated patient profiles and how to approach
- implement multidisciplinary strategies to maintain high patient satisfaction and reduce negative situations

Register now for this Master Class:
- 7am EDT / 1pm CET: http://bit.ly/AllurionMasterclass_PatientManagement
- 12pm EDT / 6pm CET: http://bit.ly/AllurionMasterclass_PatientManagement2



Not for US physicians - investigational use only in the US .
This content describes our product, which has not been approved or cleared for marketing by the U.S. Food and Drug Administration. Our product is not available for sale in the United States.